SURVEY: DR-TB patients & providers
Only half of patients who start treatment for drug-resistant TB (DR-TB) finish it successfully. The reasons are many, and often are related to non-medical challenges. USAID is working with patients, their supporters and frontline providers, to develop a patient-centered care package.
You can contribute to this effort by sharing your experiences and opinion: Please fill out this survey before 25 November to provide them with your feedback and help improve DR-TB care.
